The AHSN Network’s real-world evaluation programme aims to help innovators work with adopting organisations to secure the rapid rollout of new products.
The AHSN Network aims to ensure that innovators perform high-quality, relevant real-world evaluations that:
- demonstrate the value of a new product in real-world settings (outside of a controlled research environment)
- help organisations to implement new technology as easily as possible by building on learnings from previous rollouts in other organisations.
Read the AHSN Network guide: Real-World Evaluation to facilitate adoption at scale.
Some AHSNs have an ‘in-house’ ability to deliver this work, but many work with providers in the academic and private sectors to offer this service.
If you have an innovation that you believe can improve outcomes for patients in the UK and would like advice on conducting real-world evaluations, contact your local AHSN.
Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]
Dr Cheryl Crocker, interim Chief Operating Officer at the Health Innovation Network, explains the vital role innovation plays to not only reduce waiting lists and improve access to care, but to decrease system pressure by improving people’s health and keeping them well for longer. The new Government has rightly declared its focus on moving the [...]
Launched in 2014, SiSU Health is scaling early warning, self-service health kiosks, digital platforms and pathways into pre-existing healthcare services. The British Heart Foundation estimates the annual cardiovascular disease (CVD) related costs to the UK healthcare system are around £10 billion, with annual costs to the UK economy of an estimated £25 billion. Making the [...]
